Morgan Stanley
DWTX

Morgan Stanley’s Dogwood Therapeutics DWTX Stock Holding History

Morgan Stanley’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-477
Closed -$1.98K – 8556
2025
Q4 		$1.98K Sell
477
-123
-21% -$724 ﹤0.01% 7243
2025
Q3 		$4.62K Sell
600
-16,850
-97% -$83.9K ﹤0.01% 7113
2025
Q2 		$83.2K Buy
17,450
+16,850
+2,808% +$81.5K ﹤0.01% 6196
2025
Q1 		$3.01K Hold
600
– – ﹤0.01% 7096
2024
Q4 		$1.49K Sell
600
-8
-1% -$26 ﹤0.01% 7236
2024
Q3 		$2.58K Buy
608
+8
+1% +$41 ﹤0.01% 7079
2024
Q2 		$3.23K Hold
600
– – ﹤0.01% 6961
2024
Q1 		$7.19K Sell
600
-600
-50% -$6.74K ﹤0.01% 6801
2023
Q4 		$17.3K Buy
1,200
+600
+100% +$10.1K ﹤0.01% 6704
2023
Q3 		$13.9K Hold
600
– – ﹤0.01% 6603
2023
Q2 		$20.7K Buy
+600
New +$17.1K ﹤0.01% 6556
2023
Q1 		– Hold
0
– -$3 – 7844
2022
Q4 		– Sell
-186
Closed -$1.4K – 7848
2022
Q3 		$2K Hold
186
– – ﹤0.01% 7496
2022
Q2 		$20K Hold
186
– – ﹤0.01% 6995
2022
Q1 		$21K Buy
+186
New +$27.1K ﹤0.01% 7129
2021
Q2 		– Sell
-40
Closed -$6K – 7816
2021
Q1 		$6K Sell
40
-18
-31% -$3.13K ﹤0.01% 7071
2020
Q4 		$11K Buy
+58
New +$14K ﹤0.01% 6611

Other funds holding DWTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Morgan Stanley's DWTX Position: Q1 2026 in Review

Morgan Stanley sold out of Dogwood Therapeutics (DWTX) in Q1 2026, closing a stake of 477 shares — an estimated $1.98K sold.

Morgan Stanley first reported a position in DWTX in Q4 2020 and held it in 16 quarters. The position peaked at $83.2K in Q2 2025. 13 funds tracked by Wall St. Rank hold DWTX as of Q1 2026.

  • Morgan Stanley reported no remaining Dogwood Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 477 Dogwood Therapeutics shares in Q1 2026, an estimated $1.98K.
  • Morgan Stanley first reported a position in Dogwood Therapeutics in Q4 2020 and held it in 16 quarters.
  • Morgan Stanley's Dogwood Therapeutics position peaked at $83.2K in Q2 2025.
  • 13 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.